Literature DB >> 20518591

Delays incurred during acute myocardial infarction: a comparative study of rural and urban populations in Greece.

Ioannis Vavouranakis1, Anthi Fanioudaki, Emmanuel Lamprogiannakis, Ioannis Baltzakis, Kalliopi Sidiropoulou, Eleni Porfiri, Emmanuel S Ganotakis.   

Abstract

INTRODUCTION: Treatment delay during myocardial infarction may be due to a number of factors, such as age, sex, socioeconomic status and interpretation of symptoms. However, whether residence plays a role has not been fully investigated and, if known, could provide information that will help target specific populations. This study investigated whether urban and rural residents in Greece differ in the time required to seek and receive medical assistance during acute myocardial infarction, according to their characteristics and the determinants of their delay.
METHODS: This was an observational study (with a structured interview) conducted in one academic and one regional hospital on the island of Crete, Greece, consisting of 348 patients with confirmed myocardial infarction.
RESULTS: Patients from rural and urban areas did not differ in the decision time before seeking medical assistance (180 min vs 240 min, p=0.058). Those living in rural areas experienced a longer delay in reaching hospital once they sought assistance (50 min vs 20 min, p<0.0001). The total median delay time (4.25 hours for rural and 4.75 hours for urban patients, p=0.9) was positively affected by female sex and negatively affected by a patient's belief that symptoms were serious, and that they were heart-related.
CONCLUSIONS: Strategies should be developed to reduce the treatment delay during myocardial infarction for residents of both urban and rural areas, especially for women. Patients interpreting symptoms as being serious and originating from the heart are important for a shorter delay. A better health system is needed in rural Greece in order to deal more effectively with medical emergencies such as myocardial infarction.

Entities:  

Mesh:

Year:  2010        PMID: 20518591

Source DB:  PubMed          Journal:  Rural Remote Health        ISSN: 1445-6354            Impact factor:   1.759


  6 in total

1.  Quality-adjusted life years in macular oedema due to age-related macular degeneration, diabetes and central retinal vein occlusion: the impact of anti-VEGF agents in a tertiary centre in Greece.

Authors:  Nikolaos T Voutsas; Eleni Papageorgiou; Alexandra Tantou; Vassilis A Dimitriou; Evangelia E Tsironi; Maria Kotoula
Journal:  Int Ophthalmol       Date:  2022-04-13       Impact factor: 2.029

2.  Frequency and determinants of timely arrival among patients of acute myocardial infarction at a public sector tertiary care hospital in Karachi.

Authors:  Faryal Akber Jalbani; Shiraz Shaikh; Subhani Fatima
Journal:  Pak J Med Sci       Date:  2020 Jul-Aug       Impact factor: 1.088

3.  Current Trends for ST-segment Elevation Myocardial Infarction during the Past 5 Years in Rural Areas of China's Liaoning Province: A Multicenter Study.

Authors:  Guang-Xiao Li; Bo Zhou; Guo-Xian Qi; Bo Zhang; Da-Ming Jiang; Gui-Mei Wu; Bing Ma; Peng Zhang; Qiong-Rui Zhao; Juan Li; Ying Li; Jing-Pu Shi
Journal:  Chin Med J (Engl)       Date:  2017-04-05       Impact factor: 2.628

4.  Regional disparities in mortality after ischemic heart disease in a Brazilian state from 2006 to 2010.

Authors:  Luciano de Andrade; Vanessa Zanini; Adelia Portero Batilana; Elias Cesar Araujo de Carvalho; Ricardo Pietrobon; Oscar Kenji Nihei; Maria Dalva de Barros Carvalho
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

Review 5.  Reducing the time-lag between onset of chest pain and seeking professional medical help: a theory-based review.

Authors:  Susan K Baxter; Peter Allmark
Journal:  BMC Med Res Methodol       Date:  2013-02-06       Impact factor: 4.615

6.  Cardiac symptom attribution and knowledge of the symptoms of acute myocardial infarction: a systematic review.

Authors:  Benedikt Birnbach; Jens Höpner; Rafael Mikolajczyk
Journal:  BMC Cardiovasc Disord       Date:  2020-10-14       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.